156 related articles for article (PubMed ID: 26134097)
1. Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells.
Onabajo OO; Porter-Gill P; Paquin A; Rao N; Liu L; Tang W; Brand N; Prokunina-Olsson L
J Interferon Cytokine Res; 2015 Nov; 35(11):888-900. PubMed ID: 26134097
[TBL] [Abstract][Full Text] [Related]
2. IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.
Obajemu AA; Rao N; Dilley KA; Vargas JM; Sheikh F; Donnelly RP; Shabman RS; Meissner EG; Prokunina-Olsson L; Onabajo OO
J Immunol; 2017 Dec; 199(11):3808-3820. PubMed ID: 29070670
[TBL] [Abstract][Full Text] [Related]
3. A Novel Inactive Isoform with a Restored Reading Frame Is Expressed from the Human Interferon Lambda 4 TT Allele at rs368234815.
Bharatiya S; Agarwal A; Chinnaswamy S
J Interferon Cytokine Res; 2023 Sep; 43(9):370-378. PubMed ID: 36880961
[TBL] [Abstract][Full Text] [Related]
4. Comparative Functional Analysis of 12 Mammalian IFN-λ4 Orthologs.
Paquin A; Onabajo OO; Tang W; Prokunina-Olsson L
J Interferon Cytokine Res; 2016 Jan; 36(1):30-6. PubMed ID: 26308395
[TBL] [Abstract][Full Text] [Related]
5. IFN-λ4: the paradoxical new member of the interferon lambda family.
O'Brien TR; Prokunina-Olsson L; Donnelly RP
J Interferon Cytokine Res; 2014 Nov; 34(11):829-38. PubMed ID: 24786669
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.
Onabajo OO; Wang F; Lee MH; Florez-Vargas O; Obajemu A; Tanikawa C; Vargas JM; Liao SF; Song C; Huang YH; Shen CY; Banday AR; O'Brien TR; Hu Z; Matsuda K; Prokunina-Olsson L
Front Immunol; 2021; 12():692263. PubMed ID: 34497603
[No Abstract] [Full Text] [Related]
7. The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.
Onabajo OO; Muchmore B; Prokunina-Olsson L
J Interferon Cytokine Res; 2019 Oct; 39(10):636-641. PubMed ID: 31241411
[TBL] [Abstract][Full Text] [Related]
8. IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection.
Sung PS; Hong SH; Chung JH; Kim S; Park SH; Kim HM; Yoon SK; Shin EC
Sci Rep; 2017 Jun; 7(1):3821. PubMed ID: 28630501
[TBL] [Abstract][Full Text] [Related]
9. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.
Bhushan A; Chinnaswamy S
Gene; 2018 Jul; 664():168-180. PubMed ID: 29705128
[TBL] [Abstract][Full Text] [Related]
10. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
11. Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
Amanzada A; Kopp W; Spengler U; Ramadori G; Mihm S
PLoS One; 2013; 8(12):e84026. PubMed ID: 24376784
[TBL] [Abstract][Full Text] [Related]
12. What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?
O'Brien TR; Jackson SS
J Interferon Cytokine Res; 2019 Oct; 39(10):618-626. PubMed ID: 31161939
[TBL] [Abstract][Full Text] [Related]
13. Alcohol attenuates anti-HCV function of IFN-λ1 through up-regulation of PLASy expression in human hepatic cells.
Ran M; Huang J; Liang H; Jiang J; Liang B; Ning C; Zang N; Liao W; Liu H; Qin F; Yang Q; Ho W; Ye L; Chen H
J Med Virol; 2018 Jun; 90(6):1112-1120. PubMed ID: 29446489
[TBL] [Abstract][Full Text] [Related]
14. Monocytes differentiated into macrophages and dendritic cells in the presence of human IFN-λ3 or IFN-λ4 show distinct phenotypes.
De M; Bhushan A; Chinnaswamy S
J Leukoc Biol; 2021 Aug; 110(2):357-374. PubMed ID: 33205487
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
[TBL] [Abstract][Full Text] [Related]
16. IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18.
Fan W; Xie S; Zhao X; Li N; Chang C; Li L; Yu G; Chi X; Pan Y; Niu J; Zhong J; Sun B
J Gen Virol; 2016 Sep; 97(9):2210-2220. PubMed ID: 27302182
[TBL] [Abstract][Full Text] [Related]
17. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
19. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y
J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545
[TBL] [Abstract][Full Text] [Related]
20. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.
Prokunina-Olsson L; Muchmore B; Tang W; Pfeiffer RM; Park H; Dickensheets H; Hergott D; Porter-Gill P; Mumy A; Kohaar I; Chen S; Brand N; Tarway M; Liu L; Sheikh F; Astemborski J; Bonkovsky HL; Edlin BR; Howell CD; Morgan TR; Thomas DL; Rehermann B; Donnelly RP; O'Brien TR
Nat Genet; 2013 Feb; 45(2):164-71. PubMed ID: 23291588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
